ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/08/28 | 1,484 | 1,487 | 1,455 | 1,455 | -22 | -1.5% | 69,300 |
2017/08/25 | 1,480 | 1,483 | 1,463 | 1,477 | +45 | +3.1% | 156,400 |
2017/08/24 | 1,410 | 1,453 | 1,401 | 1,432 | +25 | +1.8% | 62,200 |
2017/08/23 | 1,393 | 1,421 | 1,393 | 1,407 | +12 | +0.9% | 38,600 |
2017/08/22 | 1,385 | 1,405 | 1,375 | 1,395 | +21 | +1.5% | 27,100 |
2017/08/21 | 1,392 | 1,395 | 1,368 | 1,374 | -35 | -2.5% | 64,200 |
2017/08/18 | 1,439 | 1,439 | 1,379 | 1,409 | -30 | -2.1% | 83,900 |
2017/08/17 | 1,411 | 1,439 | 1,408 | 1,439 | +19 | +1.3% | 56,700 |
2017/08/16 | 1,388 | 1,431 | 1,377 | 1,420 | +45 | +3.3% | 71,700 |
2017/08/15 | 1,366 | 1,385 | 1,354 | 1,375 | +12 | +0.9% | 63,200 |
2017/08/14 | 1,356 | 1,383 | 1,350 | 1,363 | -11 | -0.8% | 53,500 |
2017/08/10 | 1,396 | 1,401 | 1,352 | 1,374 | -22 | -1.6% | 100,500 |
2017/08/09 | 1,466 | 1,466 | 1,394 | 1,396 | -70 | -4.8% | 127,300 |
2017/08/08 | 1,461 | 1,495 | 1,433 | 1,466 | +5 | +0.3% | 93,000 |
2017/08/07 | 1,468 | 1,484 | 1,431 | 1,461 | -28 | -1.9% | 143,800 |
2017/08/04 | 1,360 | 1,489 | 1,360 | 1,489 | +116 | +8.4% | 252,700 |
2017/08/03 | 1,395 | 1,396 | 1,361 | 1,373 | -22 | -1.6% | 81,400 |
2017/08/02 | 1,381 | 1,420 | 1,380 | 1,395 | +10 | +0.7% | 73,100 |
2017/08/01 | 1,429 | 1,432 | 1,381 | 1,385 | -50 | -3.5% | 205,200 |
2017/07/31 | 1,451 | 1,455 | 1,430 | 1,435 | -16 | -1.1% | 85,500 |
2017/07/28 | 1,458 | 1,460 | 1,450 | 1,451 | ±0 | ±0% | 61,200 |
2017/07/27 | 1,479 | 1,482 | 1,451 | 1,451 | -23 | -1.6% | 141,700 |
2017/07/26 | 1,492 | 1,500 | 1,474 | 1,474 | -17 | -1.1% | 84,800 |
2017/07/25 | 1,490 | 1,500 | 1,486 | 1,491 | +1 | +0.1% | 49,100 |
2017/07/24 | 1,509 | 1,509 | 1,485 | 1,490 | -22 | -1.5% | 43,600 |
2017/07/21 | 1,513 | 1,517 | 1,500 | 1,512 | -1 | -0.1% | 45,300 |
2017/07/20 | 1,517 | 1,519 | 1,503 | 1,513 | +3 | +0.2% | 33,200 |
2017/07/19 | 1,485 | 1,510 | 1,484 | 1,510 | +29 | +2% | 40,500 |
2017/07/18 | 1,518 | 1,525 | 1,478 | 1,481 | -37 | -2.4% | 109,700 |
2017/07/14 | 1,528 | 1,532 | 1,518 | 1,518 | -6 | -0.4% | 37,000 |
2017/07/13 | 1,544 | 1,545 | 1,523 | 1,524 | -20 | -1.3% | 48,500 |
2017/07/12 | 1,536 | 1,551 | 1,534 | 1,544 | +9 | +0.6% | 46,600 |
2017/07/11 | 1,548 | 1,560 | 1,528 | 1,535 | -5 | -0.3% | 92,400 |
2017/07/10 | 1,549 | 1,566 | 1,533 | 1,540 | -8 | -0.5% | 86,700 |
2017/07/07 | 1,574 | 1,575 | 1,541 | 1,548 | -21 | -1.3% | 160,600 |
2017/07/06 | 1,564 | 1,576 | 1,554 | 1,569 | +1 | +0.1% | 61,000 |
2017/07/05 | 1,560 | 1,573 | 1,550 | 1,568 | -9 | -0.6% | 59,500 |
2017/07/04 | 1,566 | 1,584 | 1,544 | 1,577 | +15 | +1% | 258,700 |
2017/07/03 | 1,551 | 1,569 | 1,545 | 1,562 | +23 | +1.5% | 130,800 |
2017/06/30 | 1,539 | 1,545 | 1,531 | 1,539 | ±0 | ±0% | 47,200 |
2017/06/29 | 1,542 | 1,552 | 1,530 | 1,539 | -1 | -0.1% | 44,700 |
2017/06/28 | 1,550 | 1,552 | 1,527 | 1,540 | +1 | +0.1% | 52,400 |
2017/06/27 | 1,535 | 1,568 | 1,533 | 1,539 | +3 | +0.2% | 59,100 |
2017/06/26 | 1,525 | 1,549 | 1,525 | 1,536 | +14 | +0.9% | 75,500 |
2017/06/23 | 1,570 | 1,573 | 1,513 | 1,522 | -47 | -3% | 114,500 |
2017/06/22 | 1,555 | 1,579 | 1,541 | 1,569 | +33 | +2.1% | 112,400 |
2017/06/21 | 1,532 | 1,553 | 1,530 | 1,536 | +5 | +0.3% | 74,100 |
2017/06/20 | 1,569 | 1,569 | 1,531 | 1,531 | -28 | -1.8% | 79,300 |
2017/06/19 | 1,561 | 1,564 | 1,535 | 1,559 | -11 | -0.7% | 63,200 |
2017/06/16 | 1,576 | 1,588 | 1,555 | 1,570 | -18 | -1.1% | 110,100 |
1951~
2000
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム